GPs’ breast cancer guidelines ‘miss’ 95% of women who will develop disease
Why This Matters
Key context: <p>Findings prompt calls for review of National Institute for Health and Care Excellence criteria</p><p>Young women in England who later develop breast cancer are not being referred for early tests or preventive treatment because current guidelines used by GPs miss 95% of patients, research suggests.</p><p>The National Institute for Health and Care Excellence (Nice) criteria used to decide who should be referred by family doctors for further breast cancer risk assessment and specialist care is failing to spot the vast majority of women under 50 who will go on to develop the disease in the next 10 years, according to the University of Cambridge and the Institute of Cancer Research, London (ICR).</p> <a href="https://www.theguardian.com/society/2026/aug/04/gps-breast-cancer-guidelines-miss-95-of-women-who-will-develop-disease">Continue reading...</a> This development from The Guardian highlights ongoing changes in the sector.
Findings prompt calls for review of National Institute for Health and Care Excellence criteriaYoung women in England who later develop breast cancer are not being referred for early tests or preventive treatment because current guidelines used by GPs miss 95% of patients, research suggests.The National Institute for Health and Care Excellence (Nice) criteria used to decide who should be referred by family doctors for further breast cancer risk assessment and specialist care is failing to spot the vast majority of women under 50 who will go on to develop the disease in the next 10 years, according to the University of Cambridge and the Institute of Cancer Research, London (ICR). Continue reading...
Curation & Context
This page summarizes a public news report from The Guardian. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.